Type: Randomized controlled trial
Registration: NCT05344443
Status: Registered
Tags: Insomnia, Medication, Trial registration
External URL: https://clinicaltrials.gov/study/NCT05344443
Dual‑orexin receptor antagonist tested for insomnia complaints across night schedules.
An upcoming study is set to evaluate whether wake‑ or sleep‑promoting medication meaningfully shifts sleep, alertness, and metabolic markers for people who work nights. Quantified effects would show where medication sits alongside timing‑based approaches. The value for this audience is clarity: what’s measurable about the schedule, and where timing truly matters.
DORAs for sleep on nights.